Proteus Digital Health last week said that it raised a $50 million Series H equity round it plans to use to expand the footprint of its Discover “smart pill.” The device uses an ingestible sensor, the size of a grain of sand, which is activated when it reaches the stomach and communicates with a wearable sensor patch which […]
Proteus Digital Health
Study: Proteus Discover boosts compliance, lowers BP & LDL | ACC 2016
Proteus Digital Health yesterday presented interim results from a study of its Proteus Discover for patients with uncontrolled hypertension and type 2 diabetes, claiming use of the system raised patient compliance, lowered blood pressure and reduced low-density lipoprotein-cholesterol. The Chicago-based company’s Proteus Discover operates through the use of an ingestible sensor, the size of a grain of […]
Fujifilm Medical Systems names new COO, CMO | Personnel Moves
Fujifilm Holdings (TSE:4901) said its Fujifilm Medical Systems U.S.A. subsidiary lured an Accuray (NSDQ:ARAY) executive and a physician from the University of Southern California to its executive roster effective Sept. 28. The Stamford, Conn.-based company said Johann Fernando, formerly Accuray’s vice president & general manager, was named to be its operations chief. Dr. Diku Mandavia, who has […]
FDA to review Proteus ‘smart pill’ with Otsuka’s Abilify anti-depressant
Otsuka Pharmaceutical (TYO:4578) and Proteus Digital Health said yesterday that the FDA will review a combination of the Proteus “smart pill” and Otsuka’s Abilify anti-depressant drug. The companies said the FDA accepted their new drug application for the drug-device combination, using the Proteus ingestible sensor and Otsuka’s aripiprazole drug in patients with serious mental illnesses such as major […]
FDA adds medication adherence indication to Proteus Digital Health’s pill sensor
Proteus Digital Health today said the FDA expanded the indications for use for its sensor-enabled pill technology, claiming it as the only FDA-approved device designed to measure medication adherence. “We are delighted that our collaborative work with the FDA continues to enable positive progress,” co-founder & chief medical officer Dr. George Savage said in prepared remarks. […]
Proteus Digital closes $172M round for ingestible sensor tech | Medtech funding for the week of July 28, 2014
Medtronic-backed Proteus Digital raises $172M for sensor-enabled pills
California-based Proteus Digital Health closed a Series G funding round this week with more than $172 million pledged in support of the company’s ingestible sensor-laden pills.
MIT’s Langer wins Alpert Prize | Personnel Moves
Bob Langer, MIT professor and bioengineering hot-shot, was chosen to recieve the 2011 Alpert Prize for his advancements in drug delivery and tissue engineering.
Proteus Biomedical appoints Brinsmead as chairman
REDWOOD CITY, Calif.–(BUSINESS WIRE)–Proteus Biomedical Inc., a pioneer in intelligent medicine, announced today that Chris Brinsmead has joined the company as Chairman, Proteus Biomedical Europe. Brinsmead has over 30 years of experience in the global pharmaceutical industry and more recently advising the United Kingdom government on health and life sciences policy. He will be instrumental in guiding the commercial launch of Proteus’s first product, Helius™, and the development of Proteus’s organization in Europe.
Proteus Biomedical nabs CE Mark for ingestible sensor
European Union doctors may now begin prescribing Proteus Biomedical Inc.’s “Raisins.”
The Redwood City, Calif.-based company won CE Mark approval for its ingestible “Raisin” sensor and personal physiologic monitor system.
Proteus also announced ISO 13485:2003 certification for the system, according to a press release.